- •Preface
- •Acknowledgments
- •Contents
- •1.1 Introduction
- •1.2 Normal Embryology
- •1.3 Abnormalities of the Kidney
- •1.3.1 Renal Agenesis
- •1.3.2 Renal Hypoplasia
- •1.3.3 Supernumerary Kidneys
- •1.3.5 Polycystic Kidney Disease
- •1.3.6 Simple (Solitary) Renal Cyst
- •1.3.7 Renal Fusion and Renal Ectopia
- •1.3.8 Horseshoe Kidney
- •1.3.9 Crossed Fused Renal Ectopia
- •1.4 Abnormalities of the Ureter
- •1.5 Abnormalities of the Bladder
- •1.6 Abnormalities of the Penis and Urethra in Males
- •1.7 Abnormalities of Female External Genitalia
- •Further Reading
- •2.1 Introduction
- •2.2 Pathophysiology
- •2.3 Etiology of Hydronephrosis
- •2.5 Clinical Features
- •2.6 Investigations and Diagnosis
- •2.7 Treatment
- •2.8 Antenatal Hydronephrosis
- •Further Reading
- •3.1 Introduction
- •3.2 Embryology
- •3.3 Pathophysiology
- •3.4 Etiology of PUJ Obstruction
- •3.5 Clinical Features
- •3.6 Diagnosis and Investigations
- •3.7 Management of Newborns with PUJ Obstruction
- •3.8 Treatment
- •3.9 Post-operative Complications and Follow-Up
- •Further Reading
- •4: Renal Tumors in Children
- •4.1 Introduction
- •4.2 Wilms’ Tumor
- •4.2.1 Introduction
- •4.2.2 Etiology
- •4.2.3 Histopathology
- •4.2.4 Nephroblastomatosis
- •4.2.5 Clinical Features
- •4.2.6 Risk Factors for Wilms’ Tumor
- •4.2.7 Staging of Wilms Tumor
- •4.2.8 Investigations
- •4.2.9 Prognosis and Complications of Wilms Tumor
- •4.2.10 Surgical Considerations
- •4.2.11 Surgical Complications
- •4.2.12 Prognosis and Outcome
- •4.2.13 Extrarenal Wilms’ Tumors
- •4.3 Mesoblastic Nephroma
- •4.3.1 Introduction
- •4.3.3 Epidemiology
- •4.3.5 Clinical Features
- •4.3.6 Investigations
- •4.3.7 Treatment and Prognosis
- •4.4 Clear Cell Sarcoma of the Kidney (CCSK)
- •4.4.1 Introduction
- •4.4.2 Pathophysiology
- •4.4.3 Clinical Features
- •4.4.4 Investigations
- •4.4.5 Histopathology
- •4.4.6 Treatment
- •4.4.7 Prognosis
- •4.5 Malignant Rhabdoid Tumor of the Kidney
- •4.5.1 Introduction
- •4.5.2 Etiology and Pathophysiology
- •4.5.3 Histologic Findings
- •4.5.4 Clinical Features
- •4.5.5 Investigations and Diagnosis
- •4.5.6 Treatment and Outcome
- •4.5.7 Mortality/Morbidity
- •4.6 Renal Cell Carcinoma in Children
- •4.6.1 Introduction
- •4.6.2 Histopathology
- •4.6.4 Staging
- •4.6.5 Clinical Features
- •4.6.6 Investigations
- •4.6.7 Management
- •4.6.8 Prognosis
- •4.7 Angiomyolipoma of the Kidney
- •4.7.1 Introduction
- •4.7.2 Histopathology
- •4.7.4 Clinical Features
- •4.7.5 Investigations
- •4.7.6 Treatment and Prognosis
- •4.8 Renal Lymphoma
- •4.8.1 Introduction
- •4.8.2 Etiology and Pathogenesis
- •4.8.3 Diagnosis
- •4.8.4 Clinical Features
- •4.8.5 Treatment and Prognosis
- •4.9 Ossifying Renal Tumor of Infancy
- •4.10 Metanephric Adenoma
- •4.10.1 Introduction
- •4.10.2 Histopathology
- •4.10.3 Diagnosis
- •4.10.4 Clinical Features
- •4.10.5 Treatment
- •4.11 Multilocular Cystic Renal Tumor
- •Further Reading
- •Wilms’ Tumor
- •Mesoblastic Nephroma
- •Renal Cell Carcinoma in Children
- •Angiomyolipoma of the Kidney
- •Renal Lymphoma
- •Ossifying Renal Tumor of Infancy
- •Metanephric Adenoma
- •Multilocular Cystic Renal Tumor
- •5.1 Introduction
- •5.2 Embryology
- •5.4 Histologic Findings
- •5.7 Associated Anomalies
- •5.8 Clinical Features
- •5.9 Investigations
- •5.10 Treatment
- •Further Reading
- •6: Congenital Ureteral Anomalies
- •6.1 Etiology
- •6.2 Clinical Features
- •6.3 Investigations and Diagnosis
- •6.4 Duplex (Duplicated) System
- •6.4.1 Introduction
- •6.4.3 Clinical Features
- •6.4.4 Investigations
- •6.4.5 Treatment and Prognosis
- •6.5 Ectopic Ureter
- •6.5.1 Introduction
- •6.5.3 Clinical Features
- •6.5.4 Diagnosis
- •6.5.5 Surgical Treatment
- •6.6 Ureterocele
- •6.6.1 Introduction
- •6.6.3 Clinical Features
- •6.6.4 Investigations and Diagnosis
- •6.6.5 Treatment
- •6.6.5.1 Surgical Interventions
- •6.8 Mega Ureter
- •Further Reading
- •7: Congenital Megaureter
- •7.1 Introduction
- •7.3 Etiology and Pathophysiology
- •7.4 Clinical Presentation
- •7.5 Investigations and Diagnosis
- •7.6 Treatment and Prognosis
- •7.7 Complications
- •Further Reading
- •8.1 Introduction
- •8.2 Pathophysiology
- •8.4 Etiology of VUR
- •8.5 Clinical Features
- •8.6 Investigations
- •8.7 Management
- •8.7.1 Medical Treatment of VUR
- •8.7.2 Antibiotics Used for Prophylaxis
- •8.7.3 Anticholinergics
- •8.7.4 Surveillance
- •8.8 Surgical Therapy of VUR
- •8.8.1 Indications for Surgical Interventions
- •8.8.2 Indications for Surgical Interventions Based on Age at Diagnosis and the Presence or Absence of Renal Lesions
- •8.8.3 Endoscopic Injection
- •8.8.4 Surgical Management
- •8.9 Mortality/Morbidity
- •Further Reading
- •9: Pediatric Urolithiasis
- •9.1 Introduction
- •9.2 Etiology
- •9.4 Clinical Features
- •9.5 Investigations
- •9.6 Complications of Urolithiasis
- •9.7 Management
- •Further Reading
- •10.1 Introduction
- •10.2 Embryology of Persistent Müllerian Duct Syndrome
- •10.3 Etiology and Inheritance of PMDS
- •10.5 Clinical Features
- •10.6 Treatment
- •10.7 Prognosis
- •Further Reading
- •11.1 Introduction
- •11.2 Physiology and Bladder Function
- •11.2.1 Micturition
- •11.3 Pathophysiological Changes of NBSD
- •11.4 Etiology and Clinical Features
- •11.5 Investigations and Diagnosis
- •11.7 Management
- •11.8 Clean Intermittent Catheterization
- •11.9 Anticholinergics
- •11.10 Botulinum Toxin Type A
- •11.11 Tricyclic Antidepressant Drugs
- •11.12 Surgical Management
- •Further Reading
- •12.1 Introduction
- •12.2 Etiology
- •12.3 Pathophysiology
- •12.4 Clinical Features
- •12.5 Investigations and Diagnosis
- •12.6 Management
- •Further Reading
- •13.1 Introduction
- •13.2 Embryology
- •13.3 Epispadias
- •13.3.1 Introduction
- •13.3.2 Etiology
- •13.3.4 Treatment
- •13.3.6 Female Epispadias
- •13.3.7 Surgical Repair of Female Epispadias
- •13.3.8 Prognosis
- •13.4 Bladder Exstrophy
- •13.4.1 Introduction
- •13.4.2 Associated Anomalies
- •13.4.3 Principles of Surgical Management of Bladder Exstrophy
- •13.4.4 Evaluation and Management
- •13.5 Cloacal Exstrophy
- •13.5.1 Introduction
- •13.5.2 Skeletal Changes in Cloacal Exstrophy
- •13.5.3 Etiology and Pathogenesis
- •13.5.4 Prenatal Diagnosis
- •13.5.5 Associated Anomalies
- •13.5.8 Surgical Reconstruction
- •13.5.9 Management of Urinary Incontinence
- •13.5.10 Prognosis
- •13.5.11 Complications
- •Further Reading
- •14.1 Introduction
- •14.2 Etiology
- •14.3 Clinical Features
- •14.4 Associated Anomalies
- •14.5 Diagnosis
- •14.6 Treatment and Prognosis
- •Further Reading
- •15: Cloacal Anomalies
- •15.1 Introduction
- •15.2 Associated Anomalies
- •15.4 Clinical Features
- •15.5 Investigations
- •Further Reading
- •16: Urachal Remnants
- •16.1 Introduction
- •16.2 Embryology
- •16.4 Clinical Features
- •16.5 Tumors and Urachal Remnants
- •16.6 Management
- •Further Reading
- •17: Inguinal Hernias and Hydroceles
- •17.1 Introduction
- •17.2 Inguinal Hernia
- •17.2.1 Incidence
- •17.2.2 Etiology
- •17.2.3 Clinical Features
- •17.2.4 Variants of Hernia
- •17.2.6 Treatment
- •17.2.7 Complications of Inguinal Herniotomy
- •17.3 Hydrocele
- •17.3.1 Embryology
- •17.3.3 Treatment
- •Further Reading
- •18: Cloacal Exstrophy
- •18.1 Introduction
- •18.2 Etiology and Pathogenesis
- •18.3 Associated Anomalies
- •18.4 Clinical Features and Management
- •Further Reading
- •19: Posterior Urethral Valve
- •19.1 Introduction
- •19.2 Embryology
- •19.3 Pathophysiology
- •19.5 Clinical Features
- •19.6 Investigations and Diagnosis
- •19.7 Management
- •19.8 Medications Used in Patients with PUV
- •19.10 Long-Term Outcomes
- •19.10.3 Bladder Dysfunction
- •19.10.4 Renal Transplantation
- •19.10.5 Fertility
- •Further Reading
- •20.1 Introduction
- •20.2 Embryology
- •20.4 Clinical Features
- •20.5 Investigations
- •20.6 Treatment
- •20.7 The Müllerian Duct Cyst
- •Further Reading
- •21: Hypospadias
- •21.1 Introduction
- •21.2 Effects of Hypospadias
- •21.3 Embryology
- •21.4 Etiology of Hypospadias
- •21.5 Associated Anomalies
- •21.7 Clinical Features of Hypospadias
- •21.8 Treatment
- •21.9 Urinary Diversion
- •21.10 Postoperative Complications
- •Further Reading
- •22: Male Circumcision
- •22.1 Introduction
- •22.2 Anatomy and Pathophysiology
- •22.3 History of Circumcision
- •22.4 Pain Management
- •22.5 Indications for Circumcision
- •22.6 Contraindications to Circumcision
- •22.7 Surgical Procedure
- •22.8 Complications of Circumcision
- •Further Reading
- •23: Priapism in Children
- •23.1 Introduction
- •23.2 Pathophysiology
- •23.3 Etiology
- •23.5 Clinical Features
- •23.6 Investigations
- •23.7 Management
- •23.8 Prognosis
- •23.9 Priapism and Sickle Cell Disease
- •23.9.1 Introduction
- •23.9.2 Epidemiology
- •23.9.4 Pathophysiology
- •23.9.5 Clinical Features
- •23.9.6 Treatment
- •23.9.7 Prevention of Stuttering Priapism
- •23.9.8 Complications of Priapism and Prognosis
- •Further Reading
- •24.1 Introduction
- •24.2 Embryology and Normal Testicular Development and Descent
- •24.4 Causes of Undescended Testes and Risk Factors
- •24.5 Histopathology
- •24.7 Clinical Features and Diagnosis
- •24.8 Treatment
- •24.8.1 Success of Surgical Treatment
- •24.9 Complications of Orchidopexy
- •24.10 Infertility and Undescended Testes
- •24.11 Undescended Testes and the Risk of Cancer
- •Further Reading
- •25: Varicocele
- •25.1 Introduction
- •25.2 Etiology
- •25.3 Pathophysiology
- •25.4 Grading of Varicoceles
- •25.5 Clinical Features
- •25.6 Diagnosis
- •25.7 Treatment
- •25.8 Postoperative Complications
- •25.9 Prognosis
- •Further Reading
- •26.1 Introduction
- •26.2 Etiology and Risk Factors
- •26.3 Diagnosis
- •26.4 Intermittent Testicular Torsion
- •26.6 Effects of Testicular Torsion
- •26.7 Clinical Features
- •26.8 Treatment
- •26.9.1 Introduction
- •26.9.2 Etiology of Extravaginal Torsion
- •26.9.3 Clinical Features
- •26.9.4 Treatment
- •26.10 Torsion of the Testicular or Epididymal Appendage
- •26.10.1 Introduction
- •26.10.2 Embryology
- •26.10.3 Clinical Features
- •26.10.4 Investigations and Treatment
- •Further Reading
- •27: Testicular Tumors in Children
- •27.1 Introduction
- •27.4 Etiology of Testicular Tumors
- •27.5 Clinical Features
- •27.6 Staging
- •27.6.1 Regional Lymph Node Staging
- •27.7 Investigations
- •27.8 Treatment
- •27.9 Yolk Sac Tumor
- •27.10 Teratoma
- •27.11 Mixed Germ Cell Tumor
- •27.12 Stromal Tumors
- •27.13 Simple Testicular Cyst
- •27.14 Epidermoid Cysts
- •27.15 Testicular Microlithiasis (TM)
- •27.16 Gonadoblastoma
- •27.17 Cystic Dysplasia of the Testes
- •27.18 Leukemia and Lymphoma
- •27.19 Paratesticular Rhabdomyosarcoma
- •27.20 Prognosis and Outcome
- •Further Reading
- •28: Splenogonadal Fusion
- •28.1 Introduction
- •28.2 Etiology
- •28.4 Associated Anomalies
- •28.5 Clinical Features
- •28.6 Investigations
- •28.7 Treatment
- •Further Reading
- •29: Acute Scrotum
- •29.1 Introduction
- •29.2 Torsion of Testes
- •29.2.1 Introduction
- •29.2.3 Etiology
- •29.2.4 Clinical Features
- •29.2.5 Effects of Torsion of Testes
- •29.2.6 Investigations
- •29.2.7 Treatment
- •29.3 Torsion of the Testicular or Epididymal Appendage
- •29.3.1 Introduction
- •29.3.2 Embryology
- •29.3.3 Clinical Features
- •29.3.4 Investigations and Treatment
- •29.4.1 Introduction
- •29.4.2 Etiology
- •29.4.3 Clinical Features
- •29.4.4 Investigations and Treatment
- •29.5 Idiopathic Scrotal Edema
- •29.6 Testicular Trauma
- •29.7 Other Causes of Acute Scrotum
- •29.8 Splenogonadal Fusion
- •Further Reading
- •30.1 Introduction
- •30.2 Imperforate Hymen
- •30.3 Vaginal Atresia
- •30.5 Associated Anomalies
- •30.6 Embryology
- •30.7 Clinical Features
- •30.8 Investigations
- •30.9 Management
- •Further Reading
- •31: Disorders of Sexual Development
- •31.1 Introduction
- •31.2 Embryology
- •31.3 Sexual and Gonadal Differentiation
- •31.5 Evaluation of a Newborn with DSD
- •31.6 Diagnosis and Investigations
- •31.7 Management of Patients with DSD
- •31.8 Surgical Corrections of DSD
- •31.9 Congenital Adrenal Hyperplasia (CAH)
- •31.10 Androgen Insensitivity Syndrome (Testicular Feminization Syndrome)
- •31.13 Gonadal Dysgenesis
- •31.15 Ovotestis Disorders of Sexual Development
- •31.16 Other Rare Disorders of Sexual Development
- •Further Reading
- •Index
530 |
24 Undescended Testes (Cryptorchidism) |
|
|
–Measurements of serum electrolytes, testosterone, luteinizing hormone (LH), follicle-stimulating hormone (FSH), müllerian-inhibiting hormone (MIH), and adrenal hormones and metabolites (17-hydroxyprogesterone).
–A stimulation test using intramuscular human chorionic gonadotropin (hCG) can be done to check for evidence of testosterone production by the gonads.
–Pelvic ultrasound is useful in infants with bilateral nonpalpable testes not only to look for gonads but also to exclude the presence of a uterus.
–Ultrasonography, computed tomography or magnetic resonance imaging, are not sensitive or specific enough to detect the majority of intra-abdominal testes and surgical exploration or laparoscopy is required.
24.2Embryology and Normal Testicular Development and Descent
•Embryologically, the testes develop in the abdomen along the gonadal ridge from the primitive (indifferent) gonad. This is under the influence of several male genes.
•This occurs at about the sixth week of gestation under the influence of the SRY gene.
–The SRY gene is located on the short arm of the Y-chromosome (Yp11.3). It is responsible for initiating sex differentiation by downstream regulation of sexdetermining factors.
–This involves expression of several genes including WT1, CBX2 (M33), SF1, GATA4/ FOG2 is critical to SRY activation.
–The SOX9 gene, located on 7q24.3-25.1, is essential for early testis development.
•The second step in male sex differentiation involves internal and external genitalia differentiation.
•During the third to fifth months of intrauterine development, the cells in the testes differentiate into testosterone-producing Leydig cells, and anti-Müllerian hormone-producing
Sertoli cells. The germ cells become fetal spermatogonia.
–The developed testes have two types of cells:
•The Leydig cells
•The Sertoli cells
–The Sertoli cells produce the anti-Müllerian hormone (AMH).
–The Leydig cells produce testosterone.
–The AMH acts on its receptor in the Müllerian ducts and causes their regression.
–Testosterone acts in a critical concentrationdependent and time-dependent manner to induce male sexual differentiation.
–Testosterone acts on the androgen receptor in the Wolffian ducts to induce the formation of:
•Epididymis
•Ejaculatory ducts
•Seminal vesicles.
–The Leydig cells also produce insulin-like factor 3 (INSL3, relaxin-like factor), which play a role in the descent of testes to the scrotum.
–Testosterone is also converted to dihydrotestosterone (DHT) under the influence of 5-alpha reductase enzyme, which acts on the androgen receptor of the prostate and external genitalia to cause its masculinization.
–Binding of Testosterone and DHT to androgen receptors is necessary for androgen effect.
•The testes remain high in the abdomen until the seventh month of gestation, when they start descending from the abdomen through the inguinal canals into their final position in the scrotum.
•It has been proposed that testicular descent from the abdomen into the scrotum occurs in two phases, under control of somewhat different factors.
–The first phase:
•This involves descent of the testes from the abdomen to the entrance of the inguinal canal.
•This phase is under the influence of the anti-Müllerian hormone (AMH).
24.4 Causes of Undescended Testes and Risk Factors |
531 |
|
|
–The second phase:
•This involves descent of the testes through the inguinal canal into the scrotum.
•This phase under the influence of androgens (testosterone).
•It was shown experimentally that androgens induce the genitofemoral nerve to release calcitonin gene-related peptide (CGRP), which causes rhythmic contractions of the gubernaculum that help facilitates testicular descend into the scrotum.
•It was also suggested that the testes secret a hormone called descendin which through a paracrine effect help in testicular descent.
•In many infants with inguinal testes, further descent of the testes into the scrotum occurs in the first 6 months of life. This is attributed to the postnatal surge of gonadotropins and testosterone that normally occurs between the first and fourth months of life.
•Factors that can affect testicular descent include:
–Maldevelopment of the gubernaculum
–Deficiency or insensitivity to AMH
–Deficiency or insensitivity to androgen
–Anatomical factors that interfere with testicular descent
•Spermatogenesis continues after birth.
–In the third to fifth months of life, some of the fetal spermatogonia residing along the basement membrane become type A spermatogonia.
–More gradually, other fetal spermatogonia become type B spermatogonia and primary spermatocytes by the fifth year after birth.
–Spermatogenesis arrests at this stage until puberty.
24.3Classification
of Undescended Testes
•A testis absent from the normal scrotal position can be found any were along the “path of descent” from high in the posterior (retroperitoneal)
abdomen, just below the kidney, to the upper part of the scrotum.
–In the abdomen: These are not palpable
–In the inguinal canal
–Just above the scrotum
•Retractile testis: A testis that can easily move between the scrotum and inguinal canal.
•Ectopic testis: A testis that descended but have “wandered” from the normal path of descent to lie outside the inguinal canal.
–In the superficial inguinal pouch
–Under the skin of the thigh
–In the perineum
–Prepenile are
–In the opposite scrotum
–In the femoral canal
•Undeveloped (hypoplastic) testis
•Severely abnormal (dysgenetic) testis
•Vanished testis: This is most likely secondary to intrauterine torsion of testes with infarction and necrosis
•Ascent testis: A testis observed in the scrotum in early infancy can occasionally “reascend” (move back up) into the inguinal canal.
•Most normal-appearing undescended testis are also normal by microscopic examination, but reduced spermatogonia can be found. The tissue in undescended testes becomes more markedly abnormal (“degenerates”) in microscopic appearance between 2 and 4 years after birth. There is some evidence that early orchidopexy reduces this degeneration.
24.4Causes of Undescended Testes and Risk Factors
•In the majority of undescended testes, no definite cause can be found
•Several factors may contribute to the development of cryptorchidism including genetics, maternal health and other environmental factors. These include:
–Parents’ exposure to some pesticides
–Diabetes and obesity in the mother
–Exposure to regular alcohol consumption during pregnancy
–Cigarette smoking
532 |
24 Undescended Testes (Cryptorchidism) |
|
|
Figs. 24.4 and 24.5 Clinical photographs showing two patients with severe hypospadias and bilateral undescended testes
–Family history of undescended testicle
–The use of cosmetics by the mother
–Preeclampsia
–Prenatal exposure to a chemical called phthalate (DEHP) which is used in the manufacture of plastics
–Exposure to mild analgesics by pregnant mothers
•Premature infants and low birth weight infants are known to have a higher incidence of undescended testes.
•Intra-abdominal pressure also appears to play a role in testicular descent.
–Conditions associated with decreased pressure include:
•Prune belly syndrome
•Cloacal exstrophy
•Omphalocele
•Gastroschisis
–Each is associated with an increased risk of undescended testes.
•The effect of decreased intra-abdominal pressure is most significant during transinguinal migration to the scrotum, probably in conjunction with androgens and a patent processus vaginalis.
•Epididymal abnormalities often accompany undescended testes, but the causal relationship has not been established.
•Cryptorchidism occurs at a much higher rate in a large number of congenital malformation syndromes including:
–Down syndrome
–Prader–Willi syndrome
–Noonan syndrome
–Kallmann’s syndrome
–Laurence-Moon-Biedl syndrome
–Sever penoscrotal or perineal hypospadias (Figs. 24.4 and 24.5)
–Prune belly syndrome (Fig. 24.6)
–Spigelian hernia (Figs. 24.7, 24.8, 24.9, and 24.10)
–Omphaloceles (Figs. 24.11 and 24.12)
–Gastroschesis and Cloacal exstrophy (Figs. 24.13 and 24.14)
24.5Histopathology
•There are several histopathological changes in undescended testes.
•A significant decrease in the number of spermatogonia per tubule (S:T ratio) in undescended testes is seen as early as the second year of life.
•Undescended testes also have atrophic Leydig cells, supporting the observation that testosterone secretion is impaired in cryptorchidism during early infancy.
24.6 Classification of Abnormal Testes |
533 |
|
|
Fig. 24.6 A clinical photograph showing a patient with prune belly syndrome and undescended testes
•Patients with poor testicular histology (S:T ratio less or equal to 0.1) and at high risk for impairment of fertility may benefit from treatment with Buserelin, a luteinizing, hormone-releasing hormone (LHRH) analogue.
•There was a significant increase in mean S:T ratio in testes rebiopsied after orchiopexy and 6 months treatment with Buserelin, while there was no change seen following orchiopexy alone.
•Although the retractile testicle is considered a normal variant, some studies suggest that not all retractile testes have a benign course.
–Some ascend into the undescended position and these require orchidopexy
–Others show volume loss and histological abnormalities that are similar but less severe than those found in cryptorchid testes.
–There are also reports of infertile adults with persistent retractile testicles who have improved sperm counts after scrotal orchiopexy.
24.6Classification of Abnormal Testes
•Normally both testes are present in their normal intra-scrotal position at the time of birth.
•A testis that is absent from the normal intrascrotal position can be:
–True undescended testis: The testis can be found anywhere along the “path of testicular descent”.
•High in the posterior (retroperitoneal) abdomen
•Below the kidney
•At the inguinal ring
•In the inguinal canal
•At the upper scrotum
–Ectopic testis: This is a testis that “wandered” from the normal path of descent. Ectopic testes exit the external inguinal ring and are then misdirected away from the normal course of descent. This can be found:
•Outside the inguinal canal
•Under the skin of the thigh
•The perineum
•The opposite scrotum
•The femoral canal
•Prepenile
–Hypoplastic testis
–Dysgenetic testis
–Vanished (anorchia) testis
•The vanishing testicle is thought to be caused by intrauterine testicular torsion.
534 |
24 Undescended Testes (Cryptorchidism) |
|
|
Figs. 24.7, 24.8, 24.9, and 24.10 Clinical and intraoperative photographs showing Spegelian hernia and undescended testis
•This is most likely during late gestation since most of these testicular remnants are found below the internal inguinal ring.
•Only 20–40 % of nonpalpable testes are absent upon surgical exploration.
–Ascent testis: A testis that descended normally in the scrotum can occasionally “reascend” back up into the inguinal canal.
–Retractile testis: A testis which can move up and down between the scrotum and inguinal canal. These testes can be manipu-
lated into the scrotum and there is a high risk of ascent.
•About 70–80 % of undescended testis are unilateral.
•10–20 % of undescended testes are bilateral.
•Approximately 80 % of undescended testes are palpable and 20 % are nonpalpable.
•In 90 % of undescended testes, the testis can be felt in the inguinal canal.
•About one half of nonpalpable testes are found to be intra-abdominal, while the rest represent absent (vanishing) or atrophic testes.
24.6 Classification of Abnormal Testes |
535 |
|
|
Figs. 24.11 and 24.12 Clinical photographs showing omphaloceles and associated bilateral undescended testes
Figs. 24.13 and 24.14 Clinical photographs of gastroschesis and cloacal exstrophy which are known to be associated with undescended testis
536 |
24 Undescended Testes (Cryptorchidism) |
|
|
•A patent processus vaginalis is found in more than 90 % of patients with undescended testis
•30–80 % of undescended testes are associated with some type of epididymal abnormality (Figs. 24.15, 24.16, 24.17, and 24.18).
UNDESCENDED TESTIS
PALPABLE (80%)
NONPALPABLE (20%)
INTRA-ABDOMINAL ABSENT
TRUE |
ECTOPIC |
RETRACTILE |
UNDESCENDED
Fig. 24.15 Intraoperative photograph in child with undescended testis. Note the vas looping before it joined the testis. Note also the abnormal epididymis
Fig. 24.17 Intraoperative photograph showing bilateral undescended testes which are small in size. Note also the abnormal epididymis
Fig. 24.16 Intraoperative photograph showing undescended testis. Note the abnormal epididymis